Author:
Ness Timothy J.,Randich Alan,Su Xin,DeWitte Cary,Hildebrand Keith
Abstract
Abstract
Background
Baclofen, a clinically available GABAB receptor agonist, produces non-opioid analgesia in multiple models of pain but has not been tested for effects on bladder nociception.
Methods
A series of experiments examined the effects of systemic and spinally administered baclofen on bladder nociception in female anesthetized rats. Models of bladder nociception included those which employed neonatal and adult bladder inflammation to produce bladder hypersensitivity.
Results
Cumulative intraperitoneal dosing (1–8 mg/kg IP) and cumulative intrathecal dosing (10–160 ng IT) of baclofen led to dose-dependent inhibition of visceromotor responses (VMRs) to urinary bladder distension (UBD) in all tested models. There were no differences in the magnitude of the analgesic effects of baclofen as a function of inflammation versus no inflammation treatments. Hemodynamic (pressor) responses to UBD were similarly inhibited by IT baclofen as well as UBD-evoked excitatory responses of spinal dorsal horn neurons. The GABAB receptor antagonist, CGP 35,348, antagonized the antinociceptive effects of IT baclofen on VMRs in all tested models but did not affect the magnitude of the VMRs by itself suggesting no tonic GABAB activity was present in this preparation. Tolerance to a seven day continuous IT infusion of baclofen was not observed.
Conclusions
These data provide support for a clinical trial of baclofen as a non-opioid treatment of human bladder pain.
Funder
Medtronic
National Institute of Diabetes and Digestive and Kidney Diseases
Publisher
Springer Science and Business Media LLC
Subject
Urology,Reproductive Medicine,General Medicine
Reference102 articles.
1. Kent CN, Park C, Lindsley CW. Classics in chemical neuroscience: baclofen. ACS Chem Neurosci. 2020;11:1740–55.
2. Bendtsen L, Zakrewska JM, Abbott J, Braschinsky M, et al. European Academy of Neurology guideline on trigeminal neuralgia. Eur J Neurol. 2019;26:831–49.
3. Harmer JP, Larson BS. Pain relief from baclofen analgesia in a neuropathic pain patient who failed opioid and pharmacotherapy: case report. J Pain Palliat Care Pharmacother. 2002;16:61–4.
4. Xiao W, Naso L, Bennett GJ. Experimental studies of potential analgesics for the treatment of chemotherapy-evoked painful neuropathies. Pain Med. 2008;9:505–17.
5. Ness TJ, McNaught J, Clodfelder-Miller B, Su X. Medications used to treat bladder disorders may alter effects of neuromodulation. Neurourol Urodyn. 2020;39:1313–20.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献